April 30th 2024
A study presented at ESCMID examines the efficacy and safety of the vaccine in older populations.
Zika Vaccine Candidate Successfully Protects Mouse Models from Infection
April 14th 2017Researchers from The University of Texas Medical Branch at Galveston (UTMB) and Instituto Evandro Chagas (IEC) have published their findings on the live-attenuated vaccine candidate in the journal Nature Medicine.
Read More
Hepatitis C and the Dwindling of Research Funding
March 14th 2017Hepatitis C virus is the world’s most prevalent blood-borne viral infection for which a vaccine does not exist. To eliminate HCV infection on a global scale, experts argue that vaccine development needs to become a public health priority.
Read More
Is it Time for a Global Vaccine Injury Compensation System?
February 21st 2017In order to ensure that vaccines reach those who need them the most, experts are proposing a global vaccine injury compensation system that would ensure their safety in the event of adverse reactions from vaccines developed on shortened timelines.
Read More